PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.60%
Revenue growth similar to MDB's 9.87%. Walter Schloss would see if both companies share industry tailwinds.
12.15%
Gross profit growth similar to MDB's 11.42%. Walter Schloss would assume both firms track common industry trends.
3.51%
EBIT growth below 50% of MDB's 31.82%. Michael Burry would suspect deeper competitive or cost structure issues.
3.51%
Operating income growth under 50% of MDB's 27.79%. Michael Burry would be concerned about deeper cost or sales issues.
8.91%
Net income growth under 50% of MDB's 28.62%. Michael Burry would suspect the firm is falling well behind a key competitor.
15.38%
EPS growth at 50-75% of MDB's 29.31%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
15.38%
Diluted EPS growth at 50-75% of MDB's 29.31%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.94%
Share count expansion well above MDB's 0.85%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.94%
Diluted share count expanding well above MDB's 0.85%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
65.15%
OCF growth at 50-75% of MDB's 87.14%. Martin Whitman would question if the firm lags in monetizing sales effectively.
46.36%
FCF growth 50-75% of MDB's 84.93%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-28.72%
Negative 10Y revenue/share CAGR while MDB stands at 641.57%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-28.72%
Negative 5Y CAGR while MDB stands at 103.28%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-28.72%
Negative 3Y CAGR while MDB stands at 149.53%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
85.08%
10Y OCF/share CAGR above 1.5x MDB's 40.81%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
85.08%
5Y OCF/share CAGR is similar to MDB's 85.90%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
85.08%
3Y OCF/share CAGR 1.25-1.5x MDB's 59.27%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
13.77%
Positive 10Y CAGR while MDB is negative. John Neff might see a substantial advantage in bottom-line trajectory.
13.77%
5Y net income/share CAGR 1.25-1.5x MDB's 11.43%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
13.77%
Positive short-term CAGR while MDB is negative. John Neff would see a clear advantage in near-term profit trajectory.
171.36%
Equity/share CAGR of 171.36% while MDB is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
171.36%
Positive 5Y equity/share CAGR while MDB is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
171.36%
3Y equity/share CAGR similar to MDB's 155.95%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.31%
AR growth well above MDB's 8.44%. Michael Burry fears inflated revenue or higher default risk in the near future.
13.94%
We show growth while MDB is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.37%
Asset growth above 1.5x MDB's 0.64%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-2.32%
We have a declining book value while MDB shows 1.55%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.76%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
19.41%
We increase R&D while MDB cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.14%
We expand SG&A while MDB cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.